Agenda
- Minutes of meeting 29 September 2016
- Item 2: Chairman’s Report – Verbal report
- Item 3: Chief Executive’s Report – Verbal report
- Item 4: Taking the cancer strategy forward: programme update
- Item 5: Update on the 17/18-18/19 operational planning and contracting round
- Item 6: Sustainability and Transformation Plans
- Item 7: NHS England Corporate and NHS Performance Report
- Item 8: NHS Finance Report
- Item 9 ia: Commissioning Committee on 28 September 2016
- Item 9 ib: Commissioning Committee on 13 October 2016.
- Item 9 ic: Commissioning Committee on 17 November 2016.
- Item 9 ii: Investment Committee
- Item 9 ii: Specialised Services Commissioning Committee
Highlights :
3: Chief Executive’s Report.
- The CEO reiterated the impact of inadequate social care funding on the NHS, and in particular the prospects for achieving FYFW targets.
4: Taking the cancer strategy forward: programme update
- Sixteen cancer alliances have been established which will work alongside the STPs, and develop the delivery plans for the cancer strategy including workforce planning, radiotherapy networks, a new Quality of Life indicator for post cancer treatment and a new 28day to diagnosis standard.
6: Sustainability and Transformation Plans
- By mid-December all STP footprints will have published their plans marking the start of more intensive engagement at all levels. NHS England will provide support for engagement through its regional teams and PPE team.
- A new mechanism for “pooled decision making” will be developed from STP work.
- NHS Improvement and NHS England will be conducting a review of STP capital requests. Schemes, we will need to understand the benefit to patients, including return on investment, when they will pay back and expected clinical benefits. Focus will be on those that are ‘shovel ready’.
Supporting implementation
- “CCGs, CSUs, NHS England local and regional teams together represent a significant pool of expertise and resource, some of which could be redeployed to assist STP and other local leaders. We will be working with leading STPs to work out how we can give them greater control over these resources where doing so would support implementation.”
7: NHS England Corporate and NHS Performance Report
- Most recent NHS performance data reporting on delivery of services and their associated access and performance standards at month 6.
- Primary Care services recovery plan with Capita on target, most services expected to be fully recovered by March 2017. Performers list is still a challenge.
- NHS England Corporate Risk Register includes:
- Red/Amber - Commissioning support services - risks of disruption to service and unfunded costs associated with transition caused by CCGs procuring and transitioning services through LPF. (Unchanged)
9 ib: Commissioning Committee on 13 October 2016.
- The Committee discussed the criteria that would need to be met for CCG mergers. Discussion points included:
- The importance of clear messaging around the aims and criteria for CCG mergers and that any merger should be a targeted intervention in particular circumstances, supported by the regional director, the partners in the STP area, and local clinicians
- The importance of any merger proposal offering improved management, lower bureaucracy and strong clinical and partner engagement
- The need to ensure optimal scale so that local population management and engagement is maintained
- The importance of a clear transition plan that ensures financial control is maintained through the transition, and into the new entity.
Personal Health Budgets
- The Committee heard about progress on the personalisation and choice programme including that the uptake of PHBs is increasing across the country. Evidence is emerging to show that savings are being made where PHBs are being delivered and there are positive signs that the delivery model is being used widely to improve person-centred care. In discussion, the Committee noted the importance of ensuring effective IT systems are in place to support and facilitate the spread of the programme.
Joint assurance process
- The joint assurance process aims to develop a single integrated assurance process across the NHS for all novel contracts, including new MCP and PACS contracts. The work is being overseen by a Joint Assurance Design Group which is looking at the whole process, from pre-procurement through to implementation.
Date of Next NHS England Board meeting: 09 February 2017
